The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer

被引：53

作者：

Xiong, Guangbing ^{[1
,2
]}

Feng, Mengyu ^{[1
,2
]}

Yang, Gang ^{[1
,2
]}

Zheng, Suli ^{[1
,2
]}

Song, Xujun ^{[1
,2
]}

Cao, Zhe ^{[1
,2
]}

You, Lei ^{[1
,2
]}

Zheng, Lianfang ^{[2
,3
]}

Hu, Ya ^{[1
,2
]}

Zhang, Taiping ^{[1
,2
]}

Zhao, Yupei ^{[1
,2
]}

机构：

[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China

[2] Peking Union Med Coll, Beijing 100730, Peoples R China

[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China

来源：

CANCER LETTERS | 2017年 / 397卷

基金：

中国国家自然科学基金;

关键词：

Pancreatic cancer; Chemoresistance; microRNA; Long non-coding RNA; Mechanism; PREDICTS POOR-PROGNOSIS; GEMCITABINE RESISTANCE; DUCTAL ADENOCARCINOMA; DOWN-REGULATION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; GASTRIC-CANCER; UP-REGULATION; INCREASES CHEMORESISTANCE; RIBONUCLEOTIDE REDUCTASE;

D O I：

10.1016/j.canlet.2017.02.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic cancer, which is often asymptomatic, is currently one of the most common causes of cancer related death. This phenomenon is most likely due to a lack of early diagnosis, a high metastasis rate and a disappointing chemotherapy outcome. Thus, improving treatment outcomes by overcoming chemotherapy resistance may be a useful strategy in pancreatic cancer. Various underlying mechanisms involved in the chemoresistance of pancreatic cancer have been investigated. Notably, non-coding RNAs (ncRNAs), especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), play a pivotal role in regulating sensitivity to chemotherapy in pancreatic cancer. In this review, we highlight recent evidence regarding the role of miRNAs and IncRNAs in the chemoresistance of pancreatic cancer, including their expression levels, targets, biological functions and the regulation of chemoresistance, and discuss the potential clinical application of miRNAs and IncRNAs in the treatment of pancreatic cancer. (C) 2017 Elsevier B.V. All rights reserved.

引用

页码：94 / 102

页数：9

共 50 条

[41] Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
Lorenzo F. Sempere
Katherine Powell
Jatin Rana
Andrew A. Brock
Thomas D. Schmittgen
Cancer and Metastasis Reviews, 2021, 40 : 761 - 776
[42] Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways
Alsaab, Hashem O.
Alzahrani, Mohammad S.
Alaqile, Atheer F.
Waggas, Dania S.
Almutairy, Bandar
PATHOLOGY RESEARCH AND PRACTICE, 2024, 260
[43] HER2 puzzle pieces: Non-Coding RNAs as keys to mechanisms, chemoresistance, and clinical outcomes in Ovarian cancer
Yang, Fangwei
Yan, Lixiang
Ji, Junnan
Lou, Yunxia
Zhu, Jinlu
PATHOLOGY RESEARCH AND PRACTICE, 2024, 258
[44] Epigenetic Mechanisms and Non-coding RNAs in Osteoarthritis
Barter, Matt J.
Young, David A.
CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (09)
[45] Epigenetic Mechanisms and Non-coding RNAs in Osteoarthritis
Matt J. Barter
David A. Young
Current Rheumatology Reports, 2013, 15
[46] Non-coding RNAs and their epigenetic regulatory mechanisms
Zhou, Huihui
Hu, Hu
Lai, Maode
BIOLOGY OF THE CELL, 2010, 102 (12) : 645 - 655
[47] Long non-coding RNAs in cancer
ZhaoJian Gong
ShanShan Zhang
WenLing Zhang
HongBin Huang
Qiao Li
Hao Deng
Jian Ma
Ming Zhou
JuanJuan Xiang
MingHua Wu
XiaYu Li
Wei Xiong
XiaoLing Li
Yong Li
ZhaoYang Zeng
GuiYuan Li
Science China Life Sciences, 2012, 55 : 1120 - 1124
[48] Non-coding RNAs in human cancer
Peng, Yong
SEMINARS IN CANCER BIOLOGY, 2021, 75 : 1 - 2
[49] Regulatory mechanisms of long non-coding RNAs
Zhigang Luo
Oncology and Translational Medicine, 2019, 5 (03) : 147 - 151
[50] Non-coding RNAs in lung cancer
Tutar, Esen
Tutar, Yusuf
JOURNAL OF THORACIC DISEASE, 2019, 11 : S245 - S248

← 1 2 3 4 5 →